Please provide your email address to receive an email when new articles are posted on . Spatz, an associate professor of cardiology and epidemiology at Yale University School of Medicine, discussed ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Plozasiran reduced triglycerides, ApoC-III and non-HDL ...
Ionis Pharmaceuticals (NASDAQ: IONS) shares surged nearly 44% this past week after the developer of RNA-targeted therapies came out with positive data from two pivotal Phase III trials assessing a ...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results